Get an alert when BIOCHROM LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2025-12-31

Overdue

Confirmation statement due

2027-04-07 (in 11mo)

Last made up 2026-03-24

Watchouts

3 items

Cash

£521K

+10.6% vs 2022

Net assets

£12M

+4.6% vs 2022

Employees

36

-2.7% vs 2022

Profit before tax

£991K

+172.5% vs 2022

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Name history

Renamed 1 time since incorporation

  1. BIOCHROM LIMITED 1998-03-26 → present
  2. INTERCEDE 1313 LIMITED 1998-03-13 → 1998-03-26

Accounts

2-year trend · latest reflected 2023-12-31

Metric Trend 2022-12-312023-12-31
Turnover £12,185,885£10,979,446
Operating profit £802,962£1,247,776
Profit before tax £363,718£991,268
Net profit £363,718£991,268
Cash £470,619£520,675
Total assets less current liabilities £11,920,588£12,474,674
Net assets £11,844,963£12,392,549
Equity £11,844,963£12,392,549
Average employees 3736
Wages £1,832,782£1,799,253

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2022-12-312023-12-31
Operating margin 6.6%11.4%
Net margin 3.0%9.0%
Return on capital employed 6.7%10.0%
Current ratio 1.18x1.38x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Grant Thornton UK LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“A material uncertainty still exists that may cast significant doubt on the Company's ability to continue as a going concern, due to its reliance on financial support from its parent undertaking, which itself is dependent on successfully refinancing its debt facilities by 30 June 2025. Despite this, the financial statements have been prepared on a going concern basis and do not include any adjustments that would be required should the Company be unable to continue as a going concern.”

Group structure

  1. BIOCHROM LIMITED · parent
    1. Scie-Plas Limited 100% · England and Wales · Dormant
    2. Asys Hitech GmbH 100% · Austria · Dormant
    3. Walden Precision Apparatus Limited 100% · England and Wales · Dormant
    4. CMA Microdialysis AB 100% · Sweden · Manufacturer of laboratory equipment
    5. Multi Channel Systems GmbH 100% · Germany · Developer, manufacturer and marketer of scientific instrumentation

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 23 resigned

Name Role Appointed Born Nationality
FOLLEN, Leigh Edward Secretary 2020-11-24
EYLES, Joe Joseph Director 2014-09-23 Jul 1972 British
KARCHER, Felix Director 2025-08-29 Sep 1993 German
Show 23 resigned officers
Name Role Appointed Resigned
CZARNOBAJ, Michael David Secretary 1999-03-01 2001-05-04
EYLES, Joe Joseph Secretary 2013-11-20 2020-11-24
PETHER, Howard David James Secretary 2012-03-01 2013-11-20
RINALDI, Philip Secretary 2001-10-25 2012-02-29
TURNER, Nigel Paul Secretary 2001-05-04 2001-08-16
MITRE SECRETARIES LIMITED Corporate Nominee Secretary 1998-03-13 1999-03-01
BROWN, William Barry Director 1999-03-01 2000-07-13
COTE, Jennifer Siony Director 2024-08-20 2025-08-29
DUCHEMIN, Jeffrey Director 2013-11-20 2019-09-30
FRY, John James Director 2024-08-20 2025-08-29
GAGNON, Robert Director 2013-11-20 2018-08-31
GRAZIANO, Chancey Lee Director 1999-03-01 2013-11-20
GREEN, David Director 1999-03-01 2013-11-20
GREEN, James Walter Director 2019-09-30 2025-08-29
HEFFERNAN, James Gerard, Dr Director 2008-01-08 2010-05-14
HOUSE, John Anthony Director 2000-07-13 2001-12-31
LUKE, Samuel James Director 2010-07-12 2014-03-19
PARR, David Michael Director 2001-02-12 2008-01-11
PETHER, Howard David James Director 2013-11-20 2014-09-12
REEVES, Barbara Nominee Director 1998-03-13 1999-03-01
RICH, Michael William Nominee Director 1998-03-13 1999-03-01
STIFTER, Francis Jerome Director 2020-09-02 2024-08-20
UNNINAYAR, Kamalam Director 2018-11-26 2019-09-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Harvard Bioscience, Inc Corporate entity Shares 75–100% 2016-04-06 Ceased 2016-04-06

Filing timeline

Last 20 of 148 total filings

Date Type Category Description
2026-04-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-10 AP01 officers Appoint person director company with name date PDF
2025-09-10 TM01 officers Termination director company with name termination date PDF
2025-09-10 TM01 officers Termination director company with name termination date PDF
2025-09-10 TM01 officers Termination director company with name termination date PDF
2025-05-06 AA accounts Accounts with accounts type full
2025-04-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-27 AP01 officers Appoint person director company with name date PDF
2024-08-27 AP01 officers Appoint person director company with name date PDF
2024-08-27 TM01 officers Termination director company with name termination date PDF
2024-04-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-03-22 AA accounts Accounts with accounts type full
2023-03-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-11 AA accounts Accounts with accounts type full
2022-03-24 AD02 address Change sail address company with old address new address PDF
2022-03-24 AD02 address Change sail address company with old address new address PDF
2022-03-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-03-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-10-03 AA accounts Accounts with accounts type full
2021-04-29 MR04 mortgage Mortgage satisfy charge full PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page